Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib - PubMed20 days ago#FLT3 mutation#gilteritinib efficacy#extramedullary AMLhttps://pubmed.ncbi.nlm.nih.gov/41952620/Copy Link本研究聚焦于FLT3突变型髓外急性髓性白血病（AML）。探究了这一特定AML亚型的疾病进程。评估了治疗药物吉列替尼的疗效。